Dermatophytic Onychomycosis Therapeutics Market Size, Share, Trends, Growth, and Regional Forecasts 2025 - 2032

Dermatophytic Onychomycosis Therapeutics Market by Treatment Type (Drug-Based Treatment, Laser Therapy, Photodynamic Therapy, Combination Therapy), by Indication, by End-user, and Regional Analysis for 2025 - 2032

Analytical Snapshot of Dermatophytic Onychomycosis Therapeutics Market Report Including Regional and Country Analysis in Brief.

Industry: Healthcare

Published Date: April-2025

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 336

Report ID: PMRREP5840

Report Price

$4995*

Buy Now

Table of Content

  1. Executive Summary
    1. Global Dermatophytic Onychomycosis Therapeutics Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Treatment Adoption Analysis
    3. Disease Epidemiology
    4. Pipeline Analysis
    5. Reimbursement Scenario
    6. Value Chain Analysis
    7. Key Deals and Mergers
    8. PESTLE Analysis
    9. Porter’s Five Force Analysis
  4. Global Dermatophytic Onychomycosis Therapeutics Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
    3. Global Dermatophytic Onychomycosis Therapeutics Market Outlook: Treatment Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Treatment Type, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2025 - 2032
        1. Drug-Based Treatment
          1. Topical Antifungals
          2. Oral Antifungals
        2. Laser Therapy
        3. Photodynamic Therapy
        4. Combination Therapy
      4. Market Attractiveness Analysis: Treatment Type
    4. Global Dermatophytic Onychomycosis Therapeutics Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
        1. Distal Subungual Onychomycosis
        2. White Superficial Onychomycosis
        3. Proximal Subungual Onychomycosis
        4. Candidal Onychomycosis
        5. Total Dystrophic Onychomycosis
      4. Market Attractiveness Analysis: Indication
    5. Global Dermatophytic Onychomycosis Therapeutics Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
        1. Institutional Sales
          1. Hospitals
          2. Dermatology Clinics
        2. Retail Sales
          1. Retail Pharmacies
          2. Drug Stores
          3. Mail Order Pharmacies & Online Sales
      4. Market Attractiveness Analysis: End User
  5. Global Dermatophytic Onychomycosis Therapeutics Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Dermatophytic Onychomycosis Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
    7. Market Attractiveness Analysis
  7. Europe Dermatophytic Onychomycosis Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
    7. Market Attractiveness Analysis
  8. East Asia Dermatophytic Onychomycosis Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
    7. Market Attractiveness Analysis
  9. South Asia & Oceania Dermatophytic Onychomycosis Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
    7. Market Attractiveness Analysis
  10. Latin America Dermatophytic Onychomycosis Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
    7. Market Attractiveness Analysis
  11. Middle East & Africa Dermatophytic Onychomycosis Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Drug-Based Treatment
        1. Topical Antifungals
        2. Oral Antifungals
      2. Laser Therapy
      3. Photodynamic Therapy
      4. Combination Therapy
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Distal Subungual Onychomycosis
      2. White Superficial Onychomycosis
      3. Proximal Subungual Onychomycosis
      4. Candidal Onychomycosis
      5. Total Dystrophic Onychomycosis
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Institutional Sales
        1. Hospitals
        2. Dermatology Clinics
      2. Retail Sales
        1. Retail Pharmacies
        2. Drug Stores
        3. Mail Order Pharmacies & Online Sales
    7. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Bausch Health
        1. Overview
        2. Segments and Treatment Types
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Galderma S.A.
      3. Novartis AG
      4. Pfizer, Inc.
      5. Moberg Pharma AB
      6. Bayer AG
      7. Dr. Reddy’s Laboratories Ltd.
      8. Cipla Ltd.
      9. Medimetriks Pharmaceuticals, Inc.
      10. Sanofi S.A.
      11. GlaxoSmithKline Plc.
      12. Teva Pharmaceutical industries Ltd.
      13. Cardinal Health Inc.
      14. Viatris Inc.
      15. Almirall, S.A
      16. Vanda Pharmaceuticals Inc.
      17. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate